2016 US Venture Capital Investment into Life Sciences Companies: An Analysis by Evolution Bioscience

In order to elucidate the focus of Venture Capital funding in the Biotechnology sector this year, Evolution Analysts have assessed the deals carried out by the Top 25 US Venture

Further AgriBusiness Consolidation as Bayer Makes a $62B Bid for Monsanto

Last week German multinational Bayer put forward an all-cash $62B bid for American AgTech giant Monsanto, further emphasizing the unprecedented period of consolidation that the global AgriBusiness market is currently

Evolution M&A Analysis: China seeks food security with $43 billion bid for Syngenta

China made its boldest overseas takeover move yet this week, announcing that state-owned company ChemChina has submitted a $43 billion bid for Swiss seeds and pesticides group Syngenta with the

To CRISPR or not to CRISPR: The Ongoing Ethical Debate Surrounding Embryonic Gene Editing

The UK’s Human Fertilisation and Embryology Authority (HFEA) has given the go-ahead for a select group of Francis Crick Institute researchers to edit the genomes of human embryos. The group,

Evolution M&A Analysis: Thermo Fisher to Acquire Affymetrix for $1.3 billion

Thermo Fisher Scientific (NYSE:TMO) have announced an agreement to acquire Affymetrix (NASDAQ:AFFX) for approximately $1.3 billion, or $14.00 per share, in cash. The acquisition was unanimously approved by the boards

Arysta LifeScience announce exclusive commercial partnership at Plant Impact Investors Day

Evolution Global Talent Attraction were recently invited to crop enhancement company Plant Impact’s Investors Day at Rothamsted, where Plant Impact announced the commercial launch of BANZAI, a novel product that

Plant Impact and Bayer CropScience enter multi-year partnership

Plant Impact plc today announced that it has signed an agreement with Bayer CropScience to develop yield enhancing technologies for soy cultivation. The agreement encompasses a multi-year partnership for Plant

Merck, Sanofi, Syngenta & GSK announce full year results for 2014

Pharma giants Merck, Sanofi & GSK announced their full-year results for 2014 this week, as did global AgroChemical multinational Syngenta. Syngenta reported sales of $15.1 billion USD, achieving their integrates